Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.
about
The genetics of complex cholestatic disordersDevelopmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degenerationBilirubin: a potential biomarker and therapeutic target for diabetic nephropathy.Combined effects of smoking and bilirubin levels on the risk of lung cancer in Korea: the severance cohort studyPPARα: A Master Regulator of Bilirubin HomeostasisAssociation between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference.Associations between serum total bilirubin levels and functional dependence in the elderly.A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.Targeting heme oxygenase-1 in vascular diseaseGenetic influences on serum bilirubin in American Indians: The Strong Heart Family StudyBehavioral and clinical correlates of serum bilirubin concentrations in Japanese men and women.Direct bilirubin as a prognostic biomarker in enteric fistula patients complicated with sepsis: a case-control study.Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in menBile pigments in pulmonary and vascular diseaseThe role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseasesCigarette smoking and serum bilirubin subtypes in healthy Korean men: the Korea Medical Institute study.Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE studyHepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals.Acute alcohol consumption elevates serum bilirubin: an endogenous antioxidant.Heme oxygenase-1, oxidation, inflammation, and atherosclerosisLonger telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome.Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial CellsSerum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery diseaseBile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress.Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.Complement activation and disease: protective effects of hyperbilirubinaemia.Heme oxygenase-1: a metabolic nikeSupplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Total bilirubin in athletes, determination of reference range.Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism.Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT.Effects of serum bilirubin on atherosclerotic processes.Practical strategies for modulating foam cell formation and behavior.Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.
P2860
Q26992279-34D2BB29-3DB7-4FBD-B693-0EE820A3167CQ30493784-0DE77FF9-EDFE-4AC5-9923-A56726FB23F3Q33693385-81DC1B44-14B4-46BC-A370-AE152CAFFD82Q33853136-1F769C09-5B5F-4B31-9076-EF5FE7A9C701Q33959724-CA6A485B-F12B-4DD2-86C1-71A638C6056CQ34011326-5D4902B0-DE8C-40A7-9F10-767CC33C3C09Q34053116-6338A141-5AE9-440E-889C-6863A7E1FC4DQ34195110-FFEA298B-DCE7-4F5F-B766-90484F1AB486Q34227902-A5861E23-BA74-462A-A02F-D25ECEEF9886Q34256214-4F2A07BA-5CC0-4111-B07B-65FD6AAA16C7Q34299531-6DF551B3-ED48-4926-80D0-5781181D385DQ34614162-A4BEF1C4-9BC3-4AAC-ABE5-F005D7F48EC7Q35007341-EB47D434-2773-4CC6-B828-CA09E41D5B32Q35017088-51E438AB-8B7B-4724-B2C9-3B2F11A1C4A0Q35152249-575E2E3E-2E02-411B-AC28-8D855E9802E5Q35501103-3603256A-A96B-49FE-88DF-7A329B5B480FQ35813137-321A7D87-1A5D-4774-8DC6-EC1DE2D0E307Q35867073-B8F02FB7-D6F5-432E-9447-3645E3A096E9Q35884351-1E558E9C-30A4-47CE-91C0-498F4343AE95Q35908862-52295F7A-CEC2-46A2-B6AA-08FE478EB3DDQ35924335-5554C3EF-43DA-4EA2-A86B-C69D0414AC56Q35965680-D8A60579-2C1A-4F83-AE61-9883094A6E07Q36103851-406E60A7-6E36-445C-95BD-C8CABB9F6DD1Q36633410-D7B9E1DA-AF9F-4CBD-89EE-95D0764471B8Q36951478-A7D22115-5EFB-41AE-9FD0-6861E1D35094Q37067651-477D486B-1555-4D27-8B13-01B96003097CQ37111590-A1006102-3B8D-4CC4-867D-5EF149C6E518Q37294067-1201C745-7695-4559-A319-FA88A15A46A8Q37364279-E84BD1DF-0369-49D2-9DE4-94BEB1BD2FA1Q37609484-BA39DB1E-2544-4C40-B8C5-2878F61D9E66Q37653782-908D5FB8-259D-44D6-888E-323A441964D2Q37728038-4ED379A4-D0DA-4C24-A0B8-101653BD0E4CQ37735064-68784FEB-E035-4AF9-93BA-D58A111C50AFQ37769184-729F14EE-7BBE-4643-BA3D-F2DA32D4532CQ37997047-8B6A8A52-0A63-438E-AC64-52C70AD0305CQ38010172-EEC35C20-CE48-462E-8AEC-6F7D1CBF2C19Q38074990-E3A17972-9E1C-4306-B8AF-D0227DEBBBE7Q38203611-B3282947-C3BD-49C0-8ECA-6C84BEEB57B8Q38261037-881CA66C-EF98-4F6E-954F-69EC70BE90B4Q38424367-2ED8BE59-8E66-4975-8932-45644DF363D6
P2860
Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@ast
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@en
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@nl
type
label
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@ast
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@en
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@nl
prefLabel
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@ast
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@en
Gilbert syndrome, UGT1A1*28 al ...... tic applications of bilirubin.
@nl
P1433
P1476
Gilbert syndrome, UGT1A1*28 al ...... utic applications of bilirubin
@en
P2093
Harvey A Schwertner
P356
10.1016/J.ATHEROSCLEROSIS.2008.01.001
P50
P577
2008-03-17T00:00:00Z